FMC (US:FMC)2026-02-27 16:49Revenue and Financial Performance - Revenue charges of approximately $422 million in 2025 are driven by one-time commercial actions to prepare the India commercial business for sale[24]. - At December 31, 2025, FMC's net financial instrument position was a net liability of $9.5 million, a change from a net asset of $34.1 million at December 31, 2024[338]. - As of December 31, 2025, the net asset position was $(9.5) million, compared to a net asset position of $34.1 million at December 31, 2024[341]. Asset Management - Long-lived assets decreased from $5,171.2 million in 2024 to $3,512.6 million in 2025, with significant declines in Europe, Middle East, and Africa (from $3,685.4 million to $2,357.9 million) and Latin America (from $278.8 million to $187.6 million)[27]. - The debt portfolio composition at December 31, 2025, consisted of 82% fixed-rate debt and 18% variable-rate debt[343]. Research and Development - The company has a robust R&D pipeline featuring 16 new active areas in discovery and 19 new active ingredients in development[43]. - FMC's R&D focuses on environmentally sound solutions, with continuous investment in high-quality equipment at facilities like the FMC Stine Research Center[62]. Product Portfolio - The core portfolio includes Rynaxypyr active, generating approximately $0.8 billion in annual revenues for 2025, with a pipeline of eleven new products expected to launch this decade[42]. - The growth portfolio includes Cyazypyr active, which generated revenues of approximately $0.4 billion in 2025, with seven new products expected to launch this decade[44]. Sustainability and Environmental Goals - The company aims for net-zero GHG emissions and has established multiple sustainability goals, including waste and water management[71]. - FMC is committed to phasing out Highly Hazardous Pesticides (HHPs), which accounted for approximately 0.1% of total sales in 2025[72]. Safety and Workforce - As of December 31, 2025, FMC employed approximately 5,500 people, with 39% in Asia and 21% in North America[65]. - FMC's Total Recordable Incident Rate (TRIR) is 0.1491, placing it in the top decile of peer companies in North America for safety performance[70]. Risk Management - The primary currencies for FMC's exchange rate exposure include the U.S. dollar against the Brazilian real, Chinese yuan, and euro[339]. - FMC's risk management program includes the use of derivative contracts to minimize exposure to commodity prices, interest rates, and foreign currency exchange rates[336]. Competitive Strategy - FMC's competitive strategy includes providing advanced technology and high product quality while maintaining cost efficiency[60]. - FMC's growth strategy focuses on developing environmentally compatible solutions and acquiring complementary technologies to enhance its product portfolio[39]. Patent and Legal Matters - The company owns approximately 162 active granted U.S. patents and 2,133 active granted foreign patents as of December 31, 2025[48]. - FMC has initiated several patent enforcement proceedings against generic producers, resulting in favorable judgments and settlements in multiple countries[52]. - Atticus LLC settled a patent dispute with FMC, allowing commercialization of CTPR-containing products[55]. Investments and Collaborations - FMC Ventures continued to support collaborations and investments in start-ups focusing on disruptive technologies in 2025[41]. - The Arc™ farm intelligence platform is now available in over 25 countries across 20 million acres, helping farmers manage pest pressure more efficiently[40].